Wuxi Biortus Biosciences

company

About

Wuxi Biortus Biosciences is an innovation-driven contract research organization committed to high-quality R&D services in drug discovery.

  • 101 - 250

Details

Last Funding Type
Series A
Last Funding Money Raised
$15M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2009
Number Of Employee
101 - 250
Operating Status
Active

Wuxi Biortus Biosciences is an innovation-driven contract research organization (CRO) committed to high-quality R&D services in support of drug discovery.

To help our clients achieve their drug discovery goals, we have established five world-class research platforms. These are Recombinant Protein Production, Structural Biology (X-ray Crystallography and Cryo-EM), In Vitro Assays and Screening, Medicinal Chemistry, and Process Development. Through the years, our R&D team has developed a number of practical and innovative techniques of which some have already been granted patent.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$15M ¥200M
Wuxi Biortus Biosciences has raised a total of $15M ¥200M in funding over 2 rounds. Their latest funding was raised on Nov 5, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 5, 2021 Series B ¥200M 1 Bayland Capital Detail
Nov 13, 2020 Series A $15M 1 Bayland Capital Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Wuxi Biortus Biosciences is funded by 1 investors. Bayland Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Bayland Capital Yes Series B